Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Active Iron Prenatal is a specialized nutritional supplement developed by Solvotrin Therapeutics for use during preconception, pregnancy, and the postpartum period. The formulation utilizes a patented technology where iron biospheres are encapsulated in a whey protein shell, allowing the iron to bypass the stomach and release specifically in the small intestine. This targeted delivery mechanism is intended to maximize absorption while significantly reducing common gastrointestinal side effects such as constipation, nausea, and bloating. The product is a combination therapy featuring non-constipating iron alongside a comprehensive multivitamin containing 20 essential nutrients, including highly absorbable L-methylfolate (levomefolic acid), B vitamins, vitamin D, and zinc, to support both maternal health and fetal development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Active Iron Prenatal.